Measuring quality of life in patients with schizophrenia:an overview

References

• Hofer A, Baumgartner S, Bodner T et al. Patient outcomes in schizophrenia II: the impact of cognition. Eur. Psychiatry 20(5–6), 395–402 (2005).
   PubMed Web of Science ®Google Scholar
• Hofer A, Baumgartner S, Edlinger M et al. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur. Psychiatry, 20(5–6), 386–394 (2005).
   PubMed Web of Science ®Google Scholar
• Kasckow JW, Twamley E, Mulchahey JJ et al. Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients. Psychiatry Res. 103(1), 69–78 (2001).
   PubMed Web of Science ®Google Scholar
• Lehman AF. The well-being of chronic mental patients. Arch. Gen. Psychiatry 40(4), 369–373 (1983).
   PubMed Web of Science ®Google Scholar
• Lehman AF. The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval. Program Plann. 6(2), 143–151 (1983).
   PubMedGoogle Scholar
• Reine G, Simeoni MC, Auquier P, Loundou A, Aghababian V, Lancon C. Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments. Eur. Psychiatry 20(7), 510–519 (2005).
   PubMed Web of Science ®Google Scholar
• Cramer JA, Rosenheck R, Xu W, Thomas J, Henderson W, Charney DS. Quality of life in schizophrenia: a comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Schizophr. Bull. 26(3), 659–666 (2000).
   PubMed Web of Science ®Google Scholar
• Awad AG, Voruganti LN. Measuring quality of life in patients with schizophrenia: an update. Pharmacoeconomics 30(3), 183–195 (2012).
   PubMed Web of Science ®Google Scholar
• Halyard MY, Frost MH, Dueck A. Integrating QoL assessments for clinical and research purposes. Curr. Probl. Cancer 30(6), 319–330 (2006).
   Google Scholar
• Halyard MY, Frost MH, Dueck A, Sloan JA. Is the use of QoL data really any different than other medical testing? Curr. Probl. Cancer 30(6), 261–271 (2006).
   PubMedGoogle Scholar
• Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc. Sci. Med. 60(4), 833–843 (2005).
   PubMed Web of Science ®Google Scholar
• Gilbody SM, House AO, Sheldon TA. Psychiatrists in the UK do not use outcomes measures. National survey. Br. J. Psychiatry 180, 101–103 (2002).
   PubMed Web of Science ®Google Scholar
• Auquier P, Boyer L. Measuring patients’ views: between enthusiasm and reality. Eur. J. Cardiothorac. Surg. 41(4), 829–830 (2012).
   Google Scholar
• Awad AG. Quality-of-life assessment in schizophrenia: the unfulfilled promise. Expert Rev. Pharmacoecon. Outcomes Res. 11(5), 491–493 (2011).
   PubMed Web of Science ®Google Scholar
• Calman KC. Quality of life in cancer patients – an hypothesis. J. Med. Ethics 10(3), 124–127 (1984).
   PubMed Web of Science ®Google Scholar
• Wood-Dauphinee S, Williams JI. Reintegration to Normal Living as a proxy to quality of life. J. Chronic Dis. 40(6), 491–502 (1987).
   PubMedGoogle Scholar
• Awad AG, Voruganti LN, Heslegrave RJ. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual. Life Res. 6(1), 21–26 (1997).
   PubMed Web of Science ®Google Scholar
• Ritsner M, Gibel A, Ratner Y. Determinants of changes in perceived quality of life in the course of schizophrenia. Qual. Life Res. 15(3), 515–526 (2006).
   Google Scholar
• Zissi A, Barry MM, Cochrane R. A mediational model of quality of life for individuals with severe mental health problems. Psychol. Med. 28(5), 1221–1230 (1998).
   PubMed Web of Science ®Google Scholar
• Aghababian V, Auquier P, Baumstarck-Barrau K, Lançon C. [Relationship between insight and self-reported quality of life among shizophrenic patients]. Encephale. 37(3), 162–171 (2011).
   Google Scholar
• Boyer L, Aghababian V, Richieri R et al. Insight into illness, neurocognition and quality of life in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 36(2), 271–276 (2012).
   PubMed Web of Science ®Google Scholar
• Karow A, Pajonk FG, Reimer J et al. The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life. Eur. Arch. Psychiatry Clin. Neurosci. 258(3), 152–159 (2008).
   PubMed Web of Science ®Google Scholar
• Kurtz MM, Tolman A. Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship? Schizophr. Res. 127(1–3), 157–162 (2011).
   PubMed Web of Science ®Google Scholar
• Xiang YT, Wang Y, Wang CY et al. Association of insight with sociodemographic and clinical factors, quality of life, and cognition in Chinese patients with schizophrenia. Compr. Psychiatry 53(2), 140–144 (2012).
   Google Scholar
• Boyer L, Richieri R, Faget C et al. Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia. Psychiatry Res. 202(2), 155–160 (2012).
   PubMedGoogle Scholar
• Semerari A, Carcione A, Dimaggio G et al. How to evaluate metacognitive function in psychotherapy? The metacognition assessment scale its applications. Clin. Psychol. Psychother. 10, 238–261 (2003).
   Web of Science ®Google Scholar
• Erikson R. Welfare as a planning goal. Acta Sociologica 17(3), 273–288 (1974).
   Web of Science ®Google Scholar
• Griffin J. Well-being, Its Meaning, Measurement and Moral Importance. Clarendon Press, Oxford, UK (1986).
   Google Scholar
• Rawls J. A Theory of Justice. Oxford University Press, Oxford, UK (1971).
   Google Scholar
• Sen A. Well-being, agency and freedom. the Dewey lectures 1984. J. Phil. 82(4), 169–221 (1985).
   Web of Science ®Google Scholar
• Nordenfelt L. Toward a theory of happiness: a subjectivist notion of quality of life. In: Concepts and Measurements of Quality of Life in Health Care. Nordenfelt L (Ed.). Kluwer, Dordrecht (1994).
   Google Scholar
• Blanc J. Well-being and Amour propre: completing J. Griffin’s account of utility. Presented at: The 11th Conference of the International Society for Utilitarian Studies (ISUS), Lucca, Italy, 23–25 June 2011.
   Google Scholar
• Leplège A, Hunt S. The problem of quality of life in medicine. JAMA 278(1), 47–50 (1997).
   PubMed Web of Science ®Google Scholar
• Voruganti LN, Awad AG. Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia – findings from an in vivo SPECT study. Schizophr. Res. 88(1–3), 179–186 (2006).
   PubMed Web of Science ®Google Scholar
• Tolman AW, Kurtz MM. Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation. Schizophr. Bull. 38(2), 304–315 (2012).
   PubMed Web of Science ®Google Scholar
• Higuchi Y, Sumiyoshi T, Kawasaki Y, Matsui M, Arai H, Kurachi M. Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300. Schizophr. Res. 101(1–3), 320–330 (2008).
   PubMed Web of Science ®Google Scholar
• Sumiyoshi T, Higuchi Y, Itoh T et al. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta. Psychiatry Res. 172(3), 180–183 (2009).
   PubMed Web of Science ®Google Scholar
• Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc. Sci. Med. 48(11), 1531–1548 (1999).
   PubMed Web of Science ®Google Scholar
• Sprangers MA, Schwartz CE. The challenge of response shift for quality-of-life-based clinical oncology research. Ann. Oncol. 10(7), 747–749 (1999).
   PubMed Web of Science ®Google Scholar
• Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc. Sci. Med. 48(11), 1507–1515 (1999).
   PubMed Web of Science ®Google Scholar
• Oort FJ, Visser MR, Sprangers MA. Formal definitions of measurement bias and explanation bias clarify measurement and conceptual perspectives on response shift. J. Clin. Epidemiol. 62(11), 1126–1137 (2009).
   PubMed Web of Science ®Google Scholar
• Barclay-Goddard R, Lix LM, Tate R, Weinberg L, Mayo NE. Response shift was identified over multiple occasions with a structural equation modeling framework. J. Clin. Epidemiol. 62(11), 1181–1188 (2009).
   Google Scholar
• Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual. Life Res. 15(9), 1533–1550 (2006).
   PubMed Web of Science ®Google Scholar
• Evans S, Huxley P. Adaptation, response-shift and quality of life ratings in mentally well and unwell groups. Qual. Life Res. 14(7), 1719–1732 (2005).
   PubMed Web of Science ®Google Scholar
• Boucekine M, Loundou A, Baumstarck K et al. Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study. BMC Med. Res. Methodol. 13, 20 (2013).
   PubMed Web of Science ®Google Scholar
• Ubel PA, Peeters Y, Smith D. Abandoning the language of ‘response shift’: a plea for conceptual clarity in distinguishing scale recalibration from true changes in quality of life. Qual. Life Res. 19(4), 465–471 (2010).
   PubMedGoogle Scholar
• Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R. Quality of life assessment in clinical trials – guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office. Eur. J. Cancer 33(1), 20–28 (1997).
   PubMed Web of Science ®Google Scholar
• Acquadro C, Berzon R, Dubois D et al.; PRO Harmonization Group. Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6(5), 522–531 (2003).
   PubMed Web of Science ®Google Scholar
• Apolone G, De Carli G, Brunetti M, Garattini S. Health-related quality of life (HR-QoL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QoL measures in drug approval. Pharmacoeconomics 19(2), 187–195 (2001).
   Google Scholar
• Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur. J. Cancer 45(3), 347–353 (2009).
   PubMed Web of Science ®Google Scholar
• Evenson RC, Vieweg BW. Using a quality of life measure to investigate outcome in outpatient treatment of severely impaired psychiatric clients. Compr. Psychiatry 39(2), 57–62 (1998).
   Google Scholar
• Bobes J, García-Portilla P, Sáiz PA, Bascarán T, Bousoño M. Quality of life measures in schizophrenia. Eur. Psychiatry 20(Suppl. 3), S313–S317 (2005).
   PubMed Web of Science ®Google Scholar
• Simeoni MC, Auquier P, Lançon C, Leplege A, Simon-Abbadi S, Guelfi JD. [Critical review of measures of quality of life in schizophrenia]. Encephale. 26(4), 35–41 (2000).
   Google Scholar
• McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care 32(1), 40–66 (1994).
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31(3), 247–263 (1993).
   PubMed Web of Science ®Google Scholar
• Stein LI, Test MA. Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation. Arch. Gen. Psychiatry 37(4), 392–397 (1980).
   PubMed Web of Science ®Google Scholar
• Malm U, May PR, Dencker SJ. Evaluation of the quality of life of the schizophrenic outpatient: a checklist. Schizophr. Bull. 7(3), 477–487 (1981).
   PubMed Web of Science ®Google Scholar
• Baker F, Intagliata J. Quality of life in the evaluation of community support systems. Eval. Program Plann. 5(1), 69–79 (1982).
   PubMedGoogle Scholar
• Bigelow DA, McFarland BH, Olson MM. Quality of life of community mental health program clients: validating a measure. Community Ment. Health J. 27(1), 43–55 (1991).
   PubMed Web of Science ®Google Scholar
• Lehman AF. A quality of life interview for the chronically mentally ill. Eval. Prog. Planning 11, 51–62 (1988).
   Web of Science ®Google Scholar
• Oliver JP, Huxley PJ, Priebe S, Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc. Psychiatry Psychiatr. Epidemiol. 32(2), 76–83 (1997).
   PubMed Web of Science ®Google Scholar
• Skantze K. Defining Subjective Quality of Life Goals in Schizophrenia: the Quality of Life Self-Assessment Inventory, QLS 100,a New Approach to Successful Alliance and Service Development. Department of Psychiatry, Sahlgrenka Hospital, University of Gothenburg, Goteborg, Sweden (1993).
   Google Scholar
• Awad AG, Hogan TP. Subjective response to neuroleptics and the quality of life: implications for treatment outcome. Acta Psychiatr. Scand. Suppl. 380, 27–32 (1994).
   Google Scholar
• Hogan TP, Awad AG. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol. Med. 22(2), 347–352 (1992).
   PubMed Web of Science ®Google Scholar
• Becker M, Diamond R, Sainfort F. A new patient focused index for measuring quality of life in persons with severe and persistent mental illness. Qual. Life Res. 2(4), 239–251 (1993).
   PubMed Web of Science ®Google Scholar
• Holcomb WR, Morgan P, Adams NA, Ponder H, Farrel M. Development of a structured interview scale for measuring quality of life of the severely mentally ill. J. Clin. Psychol. 49(6), 830–840 (1993).
   PubMed Web of Science ®Google Scholar
• Heinrichs DW, Hanlon TE, Carpenter WT Jr. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 10(3), 388–398 (1984).
   PubMed Web of Science ®Google Scholar
• Boyer L, Simeoni MC, Loundou A et al. The development of the S-QoL 18: a hortened quality of life questionnaire for patients with schizophrenia. Schizophr. Res. 121(1–3), 241–250 (2010).
   PubMed Web of Science ®Google Scholar
• Auquier P, Simeoni MC, Sapin C et al. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr. Res. 63(1–2), 137–149 (2003).
   PubMed Web of Science ®Google Scholar
• Nadalet L, Kohl FS, Pringuey D, Berthier F. Validation of a subjective quality of life questionnaire (S.QUA.LA) in schizophrenia. Schizophr. Res. 76(1), 73–81 (2005).
   Web of Science ®Google Scholar
• McKenna SP. Measuring quality of life in schizophrenia. Eur. Psychiatry 12(Suppl. 3), S267–S274 (1997).
   PubMedGoogle Scholar
• Franz M, Fritz M, Gallhofer B, Meyer T. QLiS – development of a schizophrenia-specific quality-of-life scale. Health Qual. Life Outcomes 10, 61 (2012).
   Web of Science ®Google Scholar
• Gutteling JJ, Busschbach JJ, de Man RA, Darlington AS. Logistic feasibility of health related quality of life measurement in clinical practice: results of a prospective study in a large population of chronic liver patients. Health Qual. Life Outcomes 6, 97 (2008).
   Google Scholar
• Morris J, Perez D, McNoe B. The use of quality of life data in clinical practice. Qual. Life Res. 7(1), 85–91 (1998).
   PubMed Web of Science ®Google Scholar
• Takeuchi EE, Keding A, Awad N et al. Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication. J. Clin. Oncol. 29(21), 2910–2917 (2011).
   PubMed Web of Science ®Google Scholar
• Luckett T, Butow PN, King MT. Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psychooncology 18(11), 1129–1138 (2009).
   PubMed Web of Science ®Google Scholar
• Nishiyama T, Ozaki N. Measurement limit of quality-of-life questionnaires in psychiatric settings. Qual. Life Res. 19(1), 25–30 (2010).
   Google Scholar
• Voruganti L, Heslegrave R, Awad AG, Seeman MV. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol. Med. 28(1), 165–172 (1998).
   PubMed Web of Science ®Google Scholar
• Gold SM, Schulz H, Mönch A, Schulz KH, Heesen C. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult. Scler. 9(4), 404–410 (2003).
   PubMed Web of Science ®Google Scholar
• Marrie RA, Miller DM, Chelune GJ, Cohen JA. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult. Scler. 9(6), 621–626 (2003).
   PubMed Web of Science ®Google Scholar
• Baumstarck K, Pelletier J, Aghababian V et al. Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study. PLoS ONE 7(1), e30627 (2012).
   Google Scholar
• Orley J, Saxena S, Herrman H. Quality of life and mental illness. Reflections from the perspective of the WHOQoL. Br. J. Psychiatry 172, 291–293 (1998).
   PubMed Web of Science ®Google Scholar
• Prince PN, Gerber GJ. Measuring subjective quality of life in people with serious mental illness using the SEIQoL-DW. Qual. Life Res. 10(2), 117–122 (2001).
   PubMed Web of Science ®Google Scholar
• Wong JG, Cheung EP, Chen EY et al. An instrument to assess mental patients’ capacity to appraise and report subjective quality of life. Qual. Life Res. 14(3), 687–694 (2005).
   PubMedGoogle Scholar
• Boyer L, Baumstarck K, Boucekine M et al. Self-report quality of life measure is reliable and valid in patients suffering from schizophrenia with executive impairment. Patient reported outcomes and person centered care in mental health. Presented at: International Center of Mental Health Policy and Economics. Washington, DC, USA, 28–30 September 2012.
   Google Scholar
• Baumstarck K, Boyer L, Boucekine M et al. Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment. Schizophr. Res. 147(1), 58–67 (2013).
   PubMed Web of Science ®Google Scholar
• Leucht S, Tardy M, Komossa K et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet 379(9831), 2063–2071 (2012).
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J. Am. Soc. Nephrol. 12(12), 2797–2806 (2001).
   PubMed Web of Science ®Google Scholar
• Parshall MB, Mapel DW, Rice L, Williams A, O’Reilly J. Predictive validity of short-form health survey [36 items] scales for chronic obstructive pulmonary disease exacerbation. Heart Lung 37(5), 356–365 (2008).
   Google Scholar
• Sprenkle MD, Niewoehner DE, Nelson DB, Nichol KL. The Veterans Short Form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD. Chest 126(1), 81–89 (2004).
   PubMed Web of Science ®Google Scholar
• Almond S, Knapp M, Francois C, Toumi M, Brugha T. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br. J. Psychiatry 184, 346–351 (2004).
   PubMed Web of Science ®Google Scholar
• Ascher-Svanum H, Zhu B, Faries DE et al. The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry 10, 2 (2012).
   Google Scholar
• Boyer L, Auquier P. The lack of impact of quality-of-life measures in schizophrenia: a shared responsibility? Pharmacoeconomics 30(6), 531–532; author reply 532 (2012).
   PubMed Web of Science ®Google Scholar